← Open Payments lookup

STEVEN ROGERS: Open Payments

NPI 1386993509 · ROSEVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,066 in 56 payments from 17 companies in 2025. Trend: 2023 $632 · 2024 $881 · 2025 $1,066

Food & beverage: $1,066
CompanyPaymentsAmount
Novo Nordisk Inc11$205
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$189
ABBVIE INC.11$166
GlaxoSmithKline, LLC.5$88
Lilly USA, LLC3$68
Aimmune Therapeutics, Inc.3$55
SANOFI-AVENTIS U.S. LLC2$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
Teva Pharmaceuticals USA, Inc.2$33
Inspire Medical Systems, Inc.1$30

Products named: CAPLYTA, VRAYLAR, TRELEGY ELLIPTA, Wegovy, ZENPEP, Ozempic, MOUNJARO, TZIELD.

Industry payments across MI — which companies pay providers there.